Physician profile
Clifford G Robinson
NPI 1699967281
$817,468.37
in general payments reported to CMS, 2019-2025
10 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,789 · 2020: $186K · 2021: $314K · 2022: $84K · 2023: $83K · 2024: $92K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $226K · Food and Beverage: $1,048 · Travel and Lodging: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $226,372.50 |
| Food and Beverage | $1,048.04 |
| Travel and Lodging | $264.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $451,182.58 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $352,400.25 | 2021-2025 | Truebeam, Varian Ethos Treatment Planning, Aria Radiation Therapy Management Software |
| Janssen Research & Development, LLC | $5,934.19 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $4,197.95 | 2019-2024 | |
| Astrazeneca Uk Limited | $3,316.13 | 2019-2024 | Imfinzi |
| Biosense Webster, INC. | $245.12 | 2019-2023 | Carto 3 |
| Biotronik INC. | $124.97 | 2019 | |
| Empnia, INC. | $67.18 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.